{
"id":"mk19_a_np_q063",
"number":63,
"bookId":"np",
"correctAnswer":"B",
"title":"Question 63",
"stimulus":[
{
"type":"p",
"hlId":"c362ab",
"children":[
"A 25-year-old man is evaluated in the emergency department for a 1-week history of fatigue, dyspnea, and hemoptysis. He has no other medical problems and takes no medications."
]
},
{
"type":"p",
"hlId":"2a200c",
"children":[
"On physical examination, blood pressure is 155/95 mm Hg, and respiration rate is 25/min; other vital signs are normal. No rash is noted. The remainder of the examination is unremarkable."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"687cd3",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Complement, C3, serum",
"children":[
"C3"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"a3d0ba",
"class":"cell text l",
"children":[
"95 mg/dL (950 mg/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"dcfa5e",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Complement, C4, serum",
"children":[
"C4"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"312f97",
"class":"cell text l",
"children":[
"20 mg/dL (200 mg/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"e6438c",
"class":"cell text l",
"children":[
"2.3 mg/dL (203.3 µmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"b534b1",
"class":"cell text l",
"children":[
"Antinuclear antibodies"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"ffb935",
"class":"cell text l",
"children":[
"Negative"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"25d6d7",
"class":"cell text l",
"children":[
"Antimyeloperoxidase antibodies"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"ffb935",
"class":"cell text l",
"children":[
"Negative"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"8377f4",
"class":"cell text l",
"children":[
"Antiproteinase-3 antibodies"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"ffb935",
"class":"cell text l",
"children":[
"Negative"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"747c2a",
"class":"cell text l",
"children":[
"Urinalysis"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"44fb07",
"class":"cell text l",
"children":[
"3+ blood; 3+ protein; numerous erythrocytes and erythrocyte casts"
]
}
]
}
]
}
]
}
]
},
{
"type":"p",
"hlId":"e4ab3b",
"children":[
"Kidney biopsy shows necrotizing and crescentic glomerulonephritis with linear staining for IgG on immunofluorescence."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"012885",
"children":[
"Which of the following is the most appropriate serologic test to perform next?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Anti–double-stranded DNA antibodies"
}
},
{
"letter":"B",
"text":{
"__html":"Anti–glomerular basement membrane antibodies"
}
},
{
"letter":"C",
"text":{
"__html":"Anti–phospholipase A2 receptor antibodies"
}
},
{
"letter":"D",
"text":{
"__html":"Circulating IgA levels"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"dc0737",
"children":[
"Anti–glomerular basement membrane antibody disease is characterized by necrotizing and crescentic glomerulonephritis with linear staining for IgG on immunofluorescence."
]
},
{
"type":"keypoint",
"hlId":"753cc8",
"children":[
"Measurement of anti–glomerular basement membrane (anti-GBM) antibodies confirm the diagnosis of anti-GBM antibody disease and are used to monitor response to treatment."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"a0f2f5",
"children":[
"The most appropriate serologic test to perform next is measurement of anti–glomerular basement membrane (anti-GBM) antibodies (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"). This patient has rapidly progressive glomerulonephritis (RPGN), defined as an acute and steep rise in serum creatinine accompanied by hematuria and proteinuria. The differential diagnosis for RPGN is divided histologically into three patterns on immunofluorescence microscopy of the kidney biopsy: pauci-immune staining (ANCA-mediated glomerulonephritis), linear staining (anti-GBM glomerulonephritis), and granular staining (lupus nephritis). This patient has RPGN and a kidney biopsy showing linear staining, which is seen in anti-GBM antibody disease. Lung involvement (Goodpasture syndrome) occurs in >50% of patients with anti-GBM antibody disease; hemoptysis can be a presenting symptom, although shortness of breath or cough should also raise suspicion for a pulmonary-renal syndrome even in the absence of hemoptysis. Testing for anti-GBM antibodies is required as the next step in management to confirm diagnosis. For this patient, anti-GBM antibody titers would also be used to monitor treatment response. Up to one in three patients with anti-GBM antibody disease will have positive ANCA serologies, usually antimyeloperoxidase (MPO) antibodies, which can affect prognosis. Combined seropositivity is most commonly seen in patients with anti-GBM antibody disease who are older women. Therefore, it is appropriate to test for p-ANCA/anti-MPO and c-ANCA/antiproteinase 3 antibodies. Successful treatment, which typically includes glucocorticoids, plasmapheresis, and cyclophosphamide, will eradicate the patient's serum anti-GBM antibody titer."
]
},
{
"type":"p",
"hlId":"710104",
"children":[
"Testing for anti–double-stranded DNA antibodies (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") is not required in this patient, as his antinuclear antibody test is negative and his kidney biopsy shows no granular staining suggestive of lupus nephritis."
]
},
{
"type":"p",
"hlId":"dcb4e2",
"children":[
"Anti–phospholipase A2 receptor antibodies (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") can be checked in patients suspected of having primary membranous nephropathy, which typically presents with the nephrotic syndrome and preserved kidney function. The findings of erythrocytes and erythrocyte casts also argue against primary membranous nephropathy."
]
},
{
"type":"p",
"hlId":"ea6374",
"children":[
"IgA nephropathy (IgAN) can present with any of the manifestations of the nephritic syndrome. Diagnosis can only be made when kidney biopsy shows dominant mesangial immune deposits of IgA with C3, and occasionally IgG or IgM. Circulating IgA levels (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") are not diagnostically useful, nor can they be reliably correlated with disease activity and should not be obtained. This patient's kidney biopsy shows linear staining, which is not consistent with IgAN."
]
}
],
"relatedSection":"mk19_a_np_s6_4_2_3",
"objective":{
"__html":"Diagnose anti–glomerular basement membrane antibody disease."
},
"references":[
[
"Gulati K, McAdoo SP. Anti-glomerular basement membrane disease. Rheum Dis Clin North Am. 2018;44:651-673. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30274629",
"target":"_blank"
},
"children":[
"PMID: 30274629"
]
},
" doi:10.1016/j.rdc.2018.06.011"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":5,
"B":85,
"C":5,
"D":5,
"E":0
},
"hlIds":[
"c362ab",
"2a200c",
"a462a3",
"687cd3",
"a3d0ba",
"dcfa5e",
"312f97",
"f461b2",
"e6438c",
"b534b1",
"ffb935",
"25d6d7",
"ffb935",
"8377f4",
"ffb935",
"747c2a",
"44fb07",
"e4ab3b",
"012885",
"dc0737",
"753cc8",
"a0f2f5",
"710104",
"dcb4e2",
"ea6374"
]
}